BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 23515587)

  • 1. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
    Xiao J; Ho CT; Liong EC; Nanji AA; Leung TM; Lau TY; Fung ML; Tipoe GL
    Eur J Nutr; 2014 Feb; 53(1):187-99. PubMed ID: 23515587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice.
    Tipoe GL; Leung TM; Liong EC; Lau TY; Fung ML; Nanji AA
    Toxicology; 2010 Jun; 273(1-3):45-52. PubMed ID: 20438794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonol Ameliorates CCl₄-Induced Liver Injury in Rats via the NF-Kappa B and MAPK Signaling Pathways.
    Bak J; Je NK; Chung HY; Yokozawa T; Yoon S; Moon JO
    Oxid Med Cell Longev; 2016; 2016():3935841. PubMed ID: 26798422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hesperetin ameliorates hepatic oxidative stress and inflammation
    Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
    Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development.
    Li Y; Hai J; Li L; Chen X; Peng H; Cao M; Zhang Q
    Endocrine; 2013 Apr; 43(2):376-86. PubMed ID: 22843123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
    Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
    Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of liver ischemia/reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-kappaB and c-Jun expression.
    Giakoustidis DE; Giakoustidis AE; Iliadis S; Koliakou K; Antoniadis N; Kontos N; Papanikolaou V; Papageorgiou G; Kaldrimidou E; Takoudas D
    J Surg Res; 2010 Apr; 159(2):720-8. PubMed ID: 19394642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model.
    Xiao J; Ching YP; Liong EC; Nanji AA; Fung ML; Tipoe GL
    Eur J Nutr; 2013 Feb; 52(1):179-91. PubMed ID: 22278044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of green tea catechin on massive hepatectomy model in rats.
    Saito Y; Mori H; Takasu C; Komatsu M; Hanaoka J; Yamada S; Asanoma M; Ikemoto T; Imura S; Morine Y; Utsunomiya T; Shimada M
    J Gastroenterol; 2014 Apr; 49(4):692-701. PubMed ID: 23543313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGCG mediated downregulation of NF-AT and macrophage infiltration in experimental hepatic steatosis.
    Krishnan TR; Velusamy P; Srinivasan A; Ganesan T; Mangaiah S; Narasimhan K; Chakrapani LN; J T; Walter CE; Durairajan S; Nathakattur Saravanabavan S; Periandavan K
    Exp Gerontol; 2014 Sep; 57():96-103. PubMed ID: 24844145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
    Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
    J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
    Kochi T; Shimizu M; Terakura D; Baba A; Ohno T; Kubota M; Shirakami Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Lett; 2014 Jan; 342(1):60-9. PubMed ID: 23981577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
    J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats.
    Hou H; Yang W; Bao S; Cao Y
    J Oleo Sci; 2020 May; 69(5):479-486. PubMed ID: 32281563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
    Tan DY; Shi HY; Li CP; Zhong XL; Kang M
    World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease.
    Bahabadi M; Mohammadalipour A; Karimi J; Sheikh N; Solgi G; Goudarzi F; Hashemnia M; Khodadadi I
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):233-242. PubMed ID: 28555525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea catechins decrease oxidative stress in surgical menopause-induced overactive bladder in a rat model.
    Juan YS; Chuang SM; Lee YL; Long CY; Wu TH; Chang WC; Levin RM; Liu KM; Huang CH
    BJU Int; 2012 Sep; 110(6 Pt B):E236-44. PubMed ID: 22639915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
    Gao Y; Song LX; Jiang MN; Ge GY; Jia YJ
    Inflammation; 2008 Apr; 31(2):121-32. PubMed ID: 18302012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.